The market has been high on Beam Therapeutics Inc (BEAM) stock recently. BEAM gets a Bullish score from InvestorsObserver's Stock Sentiment Indicator.
What is Stock Sentiment?
Sentiment is a very short-term indicator that is entirely technical. There is no information about the health of profitability of the underlying company in our sentiment score.
As a technical indicator, news about the stock, or company, such as an earnings release or other event, could move the stock counter to the recent trend.
Price action is generally the best indicator of sentiment. For a stock to go up, investors must feel good about it. Similarly, a stock that is in a downtrend must be out of favor.
InvestorsObserver’s Sentiment Indicator considers price action and recent trends in volume. Increasing volumes often mean that a trend is strengthening, while decreasing volumes can signal that a reversal could come soon.
The options market is another place to get signals about sentiment. Since options allow investors to place bets on the price of a stock, we consider the ratio of calls and puts for stocks where options are available.
What's Happening With BEAM Stock Today?
Beam Therapeutics Inc (BEAM) stock is trading at $69.12 as of 10:48 AM on Thursday, May 13, a rise of $2.24, or 3.35% from the previous closing price of $66.88. The stock has traded between $67.44 and $72.10 so far today. Volume today is light. So far 244,466 shares have traded compared to average volume of 930,326 shares.
To see the top 5 stocks in the Biotechnology industry click here.
More About Beam Therapeutics Inc
Beam Therapeutics Inc is a biotechnology company engaged in creating genetic medicines based on its base editing technology. This technology enables a new class of genetic medicines that targets a single base in the genome without making a double-stranded break in the DNA. The company's portfolio comprises Gene Correction, Gene Modification, Gene Activation, Gene Silencing, and Multiplex Editing.
Click Here to get the full Stock Score Report on Beam Therapeutics Inc (BEAM) Stock.
